JPS5543463B2 - - Google Patents

Info

Publication number
JPS5543463B2
JPS5543463B2 JP10158973A JP10158973A JPS5543463B2 JP S5543463 B2 JPS5543463 B2 JP S5543463B2 JP 10158973 A JP10158973 A JP 10158973A JP 10158973 A JP10158973 A JP 10158973A JP S5543463 B2 JPS5543463 B2 JP S5543463B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP10158973A
Other languages
Japanese (ja)
Other versions
JPS4992080A (US06534493-20030318-C00166.png
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4992080A publication Critical patent/JPS4992080A/ja
Publication of JPS5543463B2 publication Critical patent/JPS5543463B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP10158973A 1972-09-08 1973-09-08 Expired JPS5543463B2 (US06534493-20030318-C00166.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US287423A US3862190A (en) 1972-09-08 1972-09-08 5-(unsubstituted and substituted phenoxy)-4-amino pyrimidines

Publications (2)

Publication Number Publication Date
JPS4992080A JPS4992080A (US06534493-20030318-C00166.png) 1974-09-03
JPS5543463B2 true JPS5543463B2 (US06534493-20030318-C00166.png) 1980-11-06

Family

ID=23102839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10158973A Expired JPS5543463B2 (US06534493-20030318-C00166.png) 1972-09-08 1973-09-08

Country Status (13)

Country Link
US (1) US3862190A (US06534493-20030318-C00166.png)
JP (1) JPS5543463B2 (US06534493-20030318-C00166.png)
AR (1) AR202106A1 (US06534493-20030318-C00166.png)
AU (1) AU471279B2 (US06534493-20030318-C00166.png)
BE (1) BE804414A (US06534493-20030318-C00166.png)
CA (1) CA996116A (US06534493-20030318-C00166.png)
CH (1) CH581121A5 (US06534493-20030318-C00166.png)
DE (1) DE2344611A1 (US06534493-20030318-C00166.png)
ES (1) ES418567A1 (US06534493-20030318-C00166.png)
FI (1) FI59796C (US06534493-20030318-C00166.png)
FR (1) FR2198753B1 (US06534493-20030318-C00166.png)
GB (1) GB1434805A (US06534493-20030318-C00166.png)
NL (1) NL7312270A (US06534493-20030318-C00166.png)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57164686U (US06534493-20030318-C00166.png) * 1981-04-11 1982-10-16
JPS6197973U (US06534493-20030318-C00166.png) * 1984-12-03 1986-06-23
JPS63135868U (US06534493-20030318-C00166.png) * 1987-02-26 1988-09-06

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941889A (en) * 1972-09-08 1976-03-02 Pfizer Inc. 5-(Substituted phenoxy)-4-amino pyrimidines as anti-ulcer agents
WO1998014430A1 (fr) * 1996-10-02 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Derives de pyrimidine
US6440965B1 (en) * 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
US6583148B1 (en) * 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
ATE469132T1 (de) * 2000-07-24 2010-06-15 Krenitsky Pharmaceuticals Inc Substituierte 5-alkinyl-pyrimidine mit neurotropher wirkung
CN103339114A (zh) 2010-12-24 2013-10-02 日本农药株式会社 苄氧基嘧啶衍生物,包含该衍生物的农业/园艺用杀虫剂及其使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB886693A (en) * 1959-03-04 1962-01-10 Ici Ltd Heterocyclic compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57164686U (US06534493-20030318-C00166.png) * 1981-04-11 1982-10-16
JPS6197973U (US06534493-20030318-C00166.png) * 1984-12-03 1986-06-23
JPS63135868U (US06534493-20030318-C00166.png) * 1987-02-26 1988-09-06

Also Published As

Publication number Publication date
FR2198753A1 (US06534493-20030318-C00166.png) 1974-04-05
ES418567A1 (es) 1976-08-01
CA996116A (en) 1976-08-31
DE2344611A1 (de) 1974-03-14
FI59796C (fi) 1981-10-12
GB1434805A (en) 1976-05-05
JPS4992080A (US06534493-20030318-C00166.png) 1974-09-03
CH581121A5 (US06534493-20030318-C00166.png) 1976-10-29
NL7312270A (US06534493-20030318-C00166.png) 1974-03-12
AR202106A1 (es) 1975-05-15
FR2198753B1 (US06534493-20030318-C00166.png) 1976-09-03
BE804414A (fr) 1974-03-04
AU6003173A (en) 1975-03-06
FI59796B (fi) 1981-06-30
US3862190A (en) 1975-01-21
AU471279B2 (en) 1976-04-15

Similar Documents

Publication Publication Date Title
JPS4999123A (US06534493-20030318-C00166.png)
JPS4889807A (US06534493-20030318-C00166.png)
FR2234393B1 (US06534493-20030318-C00166.png)
FR2193444A5 (US06534493-20030318-C00166.png)
JPS4992080A (US06534493-20030318-C00166.png)
CS163294B2 (US06534493-20030318-C00166.png)
JPS55944B2 (US06534493-20030318-C00166.png)
JPS4951298A (US06534493-20030318-C00166.png)
CS158828B1 (US06534493-20030318-C00166.png)
JPS4982411U (US06534493-20030318-C00166.png)
CS161286B1 (US06534493-20030318-C00166.png)
JPS4929061A (US06534493-20030318-C00166.png)
CS158470B1 (US06534493-20030318-C00166.png)
CS159499B1 (US06534493-20030318-C00166.png)
CS157575B1 (US06534493-20030318-C00166.png)
CS157372B1 (US06534493-20030318-C00166.png)
CS163905B1 (US06534493-20030318-C00166.png)
CS157351B1 (US06534493-20030318-C00166.png)
CS160385B1 (US06534493-20030318-C00166.png)
CS160017B1 (US06534493-20030318-C00166.png)
CH565954A5 (US06534493-20030318-C00166.png)
CH111172A4 (US06534493-20030318-C00166.png)
CH563202A5 (US06534493-20030318-C00166.png)
CH563094A5 (US06534493-20030318-C00166.png)
CH562928A5 (US06534493-20030318-C00166.png)